Friday, May 29, 2020

Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer | NEJM

Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer | NEJM

No comments:

Post a Comment